Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
Status:
Completed
Trial end date:
2018-05-04
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, double-dummy, active-controlled,
dose-finding study to compare the efficacy, safety and tolerability of oral SCY-078 versus
oral fluconazole in adult female subjects 18 years and older with moderate to severe Acute
Vulvovaginal Candidiasis (AVVC). Approximately 180 eligible subjects (30 subjects per
treatment group) will be enrolled and randomized into the study.